Details for New Drug Application (NDA): 017603
✉ Email this page to a colleague
NDA 017603 describes NOVAFED, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. Additional details are available on the NOVAFED profile page.
The generic ingredient in NOVAFED is pseudoephedrine hydrochloride. There are forty-nine drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the pseudoephedrine hydrochloride profile page.
The generic ingredient in NOVAFED is pseudoephedrine hydrochloride. There are forty-nine drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the pseudoephedrine hydrochloride profile page.
Summary for 017603
| Tradename: | NOVAFED |
| Applicant: | Sanofi Aventis Us |
| Ingredient: | pseudoephedrine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 120MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
